JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Home・Akcijų sąrašas・NeoGenomics Inc

NeoGenomics Inc

Uždarymo kaina

12.39 0.65

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.17

Max

12.57

Pagrindiniai rodikliai
By Trading Economics
Pajamos	18M -27M
Pardavimai	6.5M 188M
Pelno marža	-14.446
Darbuotojai	2,200
EBITDA	38M -10M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+13.09% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-17

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	296M 1.6B
Ankstesnė atidarymo kaina	11.74
Ankstesnė uždarymo kaina	12.39

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

7.7 / 10.27 Palaikymas ir pasipriešinimas

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-26 15:27; UTC

Pagrindinės rinkos jėgos

Blue Gold Rises on Issuance of Gold-Backed Digital Assets

2026-01-29 13:38; UTC

Rinkos pokalbiai

Bitcoin, Ether Shrug Off Tech-Led Gains in U.S. Stock Indices -- Market Talk

2026-01-29 08:29; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-01-29 08:29; UTC

Rinkos pokalbiai

Bitcoin Leads Fall in Cryptocurrencies Amid Iran Tensions -- Market Talk

2026-01-28 13:01; UTC

Įsigijimai, susijungimai, perėmimai

DDC Strengthens Bitcoin Treasury With Additional 100 BTC

2026-01-28 10:38; UTC

Rinkos pokalbiai

Bitcoin Edges Higher in Cautious Trade Ahead of Fed Decision -- Market Talk

2026-01-28 02:11; UTC

Rinkos pokalbiai

Cryptocurrencies Gain Ahead of Fed Rate Decision -- Market Talk

2026-01-27 11:28; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2026-01-27 11:28; UTC

Rinkos pokalbiai

Delay to Crypto Bill Highlights Risk of Stablecoins to U.S. Banks -- Market Talk

2026-01-27 09:38; UTC

Rinkos pokalbiai

Fed Announcement Could Be Key for Crypto; Bitcoin Confined to Tight Range -- Market Talk

2026-01-27 08:14; UTC

Rinkos pokalbiai

Bitcoin Rises on Optimism Over Upcoming Big Tech Earnings -- Market Talk

2026-01-26 13:55; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-26 13:55; UTC

Rinkos pokalbiai

Cryptocurrencies Could Benefit From Rebalancing Flows -- Market Talk

2026-01-26 09:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-01-26 08:17; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-26 08:17; UTC

Rinkos pokalbiai

Bitcoin Remains Weak Ahead of Fed Decision, Tech Earnings -- Market Talk

2026-01-23 08:14; UTC

Rinkos pokalbiai

Bitcoin Struggles to Recover Meaningfully Amid U.S. Crypto Bill Uncertainty -- Market Talk

2026-01-22 09:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-01-22 09:09; UTC

Rinkos pokalbiai

DAVOS: 'Tokenizations' Can Help Governments to Develop Financial Industries, Binance Founder Changpeng Zhao Says -- Market Talk

2026-01-22 08:32; UTC

Rinkos pokalbiai

DAVOS: Bitcoin Falls as it Fails to Sustain Recovery on Reduced Greenland Fears -- Market Talk

2026-01-22 06:18; UTC

Rinkos pokalbiai

DAVOS: India Could Be Key as Binance Aims for 1 Billion Users -- Market Talk

2026-01-21 14:44; UTC

Rinkos pokalbiai

DAVOS: Bitcoin Recovers After Trump Rules Out Taking Greenland by Force -- Market Talk

2026-01-21 12:49; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-21 12:48; UTC

Rinkos pokalbiai

DAVOS: Bitcoin's Falls Challenge 'Digital Gold' Argument -- Market Talk

2026-01-21 08:18; UTC

Rinkos pokalbiai

DAVOS: Bitcoin Leads Fall in Cryptocurrencies as U.S.-Europe Tensions Weigh -- Market Talk

2026-01-21 08:18; UTC

Rinkos pokalbiai

DAVOS: Global Forex and Fixed Income Roundup: Market Talk

2026-01-20 13:42; UTC

Rinkos pokalbiai

Cryptocurrencies Fall as Risk Aversion Drives Global Stocks Lower -- Market Talk

2026-01-20 11:53; UTC

Uždarbis

U.S. Bancorp Says It Has Completed Pilot to Enable Cross-Border Stablecoin Transactions >USB

2026-01-20 08:13; UTC

Rinkos pokalbiai

Bitcoin, Ether Fall on Risk Aversion Over U.S.-Europe Tensions -- Market Talk

2026-01-19 13:29; UTC

Rinkos pokalbiai

Recovery in Bitcoin, Ether Stall Amid U.S.-Europe Tensions -- Market Talk

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

13.09% į viršų

12 mėnesių prognozė

Vidutinis 14 USD 13.09%

Aukščiausias 16 USD

Žemiausias 12 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių NeoGenomics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.